```json
{
"content": [
{
"type": "paragraph",
"content": "Application is a key axis of ERCP Device segmentation, driving demand through procedural specificity. Biliary sphincterotomy, the most prevalent application, accounts for ~45% of the market, reflecting its critical role in treating bile duct obstructions. Papillotomy, used for removing gallstones or stents, contributes ~30% and is growing due to rising endoscopic interventions. Cholangiography, enabling visualization of bile ducts, comprises ~25% of the market. These applications collectively define the ERCP Device market size, with biliary procedures dominating due to higher incidence of cholelithiasis and pancreatic disorders. Technological advancements in imaging and stent placement further diversify application scope, ensuring sustained market growth."
},
{
"type": "paragraph",
"content": Types of ERCP devices under market taxonomy are classified by functional design. Sphincterotomes (60% of revenue) are the dominant segment, utilized for incising the sphincter of Oddi during biliary access. Their market share is driven by procedural frequency and integration with high-precision catheters. Biopsy forceps (40% of revenue) are essential for tissue sampling in diagnostic ERCP, with demand increasing alongside early-stage cancer detection protocols. Other types, such as stent placement tools, remain niche but are gaining traction. This typology underscores the market’s reliance on procedural complexity and evolving patient needs, with sphincterotomes and biopsy forceps forming the backbone of ERCP Device market dynamics."
}
],
"chartData": {
"segments": [
{ "name": "Biliary Sphincterotomy", "value": 45 },
{ "name": "Papillotomy", "value": 30 },
{ "name": "Cholangiography", "value": 25 }
]
}
}
```
